Close

Press Releases

PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays

PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today that it has...

CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing

CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT and Stemina have entered into a strategic partnership. Under...

Personalized medicine: The partnership imperative

Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of...

Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines

Eli Lilly and Company announced that the Mirror Portfolio, a concept created by Lilly to access innovation being developed outside the company's walls, has...

Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278

Gilead Sciences, Inc. announced that it has refiled a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the single-tablet...

Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline

Elan plc and Boehringer Ingelheim announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics. Under the terms...

Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day

On World Cancer Day, new independent evidence confirms that the increasing global trend of unhealthy and sedentary lifestyles is responsible for putting millions at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read